questionnaire as having at least 2 of these risk factors, were deemed high risk for sleep apnea.
from subjects and mathematical modeling, the heat signal from expired air is converted to a signal constituting an airflow channel and is integrated into the existing polysomnographic software as a separate channel. We evaluated the efficacy of IR-I as an alternative airflow channel during polysomnography in comparison with the conventional methods of nasal pressure, nasal-oral thermistors and capnography.
METHODS: Mean thermal measurements were performed continuously in real time at the nostrils or the mouth of subjects during one hour of polysomnography with simultaneous recording of nasal pressure, nasal-oral thermistor, expired CO2, IR-I, abdominal and thoracic excursion via piezocrystals and/or impedance plethysmography. To minimize bias, single airflow channel was scored separately without visualization of the other flow channels.
RESULTS: Thirteen subjects (9 men, 4 women) without known sleep apnea were studied. The range for age was 24 to 61 years, BMI:19.7 to 40.5 kg/m2, and Epworth Score: 1 to 19. 10.5 hours of sleep was recorded from 13 subjects. Flow-time trace generated by IR-I closely resembled that of the other airflow channels during sleep and wakefulness (figure 1). 22 sleep-disordered breathing events by thermistor, 19 by nasal pressure and 20 by IR-I were detected. One "false positive" event was detected by IR-I. The kappa statistic for thermistor versus IR-I was 0.90, nasal pressure versus IR-I was 0.76, thermistor versus nasal pressure was 0.87 (figure 2).
CONCLUSION: This is the first report of remote thermal imaging as a method to monitor airflow and detect airflow abnormalities during sleep. There was a near perfect agreement between remote IR-I and standard thermistors.
CLINICAL IMPLICATIONS: This novel "virtual thermistor" provides a non-contact method to aid in the diagnosis of sleep apnea and represents an alternative to standard nasal-oral thermistors and as an adjunct to nasal pressure. 
PURPOSE: The International Classification of Sleep Disorders 2nd
Edition (ICSD-2) defines obstructive sleep apnea (OSA) based on scoreable respiratory events which included apneas, hypopneas, and respiratory effort related arousals (RERAS) while Center for Medicare and Medicaid (CMS) uses apneas plus hypopneas. We hypothesize that CMS criteria may underdiagnose OSA because of exclusion of RERAS. We compared the impact of ICSD-2 versus CMS criteria on the diagnosis of OSA.
METHODS:
We retrospectively compared the effect of using the ICSD-2 (RDI Ն 15, AHI Ͻ 10) vs. CMS criteria (AHI between 15-30) to diagnose significant OSA on polysomnography (PSG) parameters, Epworth Sleepiness Scales (ESS), Pittsburgh Sleep Quality Index (PSQI), Fatigue Severity Scale (FSS) and prevalence of co-morbidities (hypertension, diabetes mellitus and depression) using Mann-Whitney U statistical method.
RESULTS: 100 consecutive patients with suspected OSA undergoing PSG, were analyzed. Comparison of patient groups (ICSD-2 vs. CMS group) did not reveal any significant difference in associated sleep efficiency, Stages I &II, Stage Delta, Stage REM or spontaneous arousals, suggesting comparable sleep disruption. The use of AHI was associated with a significantly lower mean SaO2 (83% AHI vs. 87% RDI). No significant difference was noted in the subjective measures of daytime functioning. Prevalence of hypertension was higher using the RDI (54% RDI vs. 27% in the AHI).
CONCLUSION: Inclusion of RERAs in the ICSD-2 criteria impacts classification of the severity of SDB. The AHI criteria, which exclude RERAS, tend to select patients with significantly worse nocturnal hypoxemia.
CLINICAL IMPLICATIONS: The CMS criteria for the diagnosis of OSA may underdiagnose patients with SDB and related co-morbidities, i.e., hypertension. 
